{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:40:19Z","timestamp":1793835619802,"version":"4.6.1"},"reference-count":81,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Clin Med\ufffdInsights\ufffdReprod\ufffdHealth"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is a common endocrine disorder among women of childbearing age, affecting 8%\u201313% globally, associated with hyperandrogenism, anovulation, insulin resistance, cardiovascular diseases, and psychological issues, contributing to infertility and long-term health risks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To estimate the prevalence of PCOS and its association with infertility, hormonal disturbances, metabolic comorbidities, and lifestyle factors among reproductive-aged women in the Barak Valley region of Assam, Northeast India\u2014an ethnically diverse and underserved area where genetic, lifestyle, and healthcare disparities may influence the prevalence and clinical presentation of PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Case-control study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A pre-validated questionnaire-based screening and multi-stage stratified random sampling method was applied among women aged 18\u201340\u2009years based on Rotterdam criteria (2003) and NHMRC guidelines (2018). Clinical and biochemical hyperandrogenism, anthropometric, metabolic, hormonal, and ultrasonographic parameters were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The prevalence of PCOS was 9.18% (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u200953), with higher occurrence among native Bengali women. Phenotypes A, B, C, and D were identified at 39.62%, 20.75%, 7.54%, and 32.07%, respectively. Clinical hyperandrogenism manifested as acne (49.05%), hirsutism (43.39%), and alopecia (28.3%), while biochemical hyperandrogenism was observed in 92.45% based on elevated free testosterone levels. Menstrual issues involved oligomenorrhea (45.28%), amenorrhea (30.18%), and dysmenorrhea (33.96%). Metabolic abnormalities such as type II diabetes (52.83%), overweight (30.18%), obesity (9.43%), and obstructive sleep apnea (37.73%) were frequent. Elevated BMI, waist\u2013hip ratio, luteinizing hormone (LH), anti-M\u00fcllerian hormone, and LH\/FSH (follicle-stimulating hormone) ratio were observed. Free testosterone correlated strongly with clinical symptoms. Urban women reported poorer dietary habits (61.36%). Family history of PCOS and anxiety were commonly associated factors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>PCOS in Barak Valley shows strong hormonal and metabolic abnormalities that may be influenced by lifestyle factors and underlying genetic predisposition. Early detection, targeted lifestyle changes, and regional awareness strategies are essential for improving reproductive and metabolic outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/26334941251384195","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:52:31Z","timestamp":1762429951000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":10,"title":["Prevalence of polycystic ovary syndrome (PCOS) and its associated hormonal and comorbid risk factors in Northeast India: a cross-sectional comparative study"],"prefix":"10.1177","volume":"19","author":[{"given":"Afrin","family":"Yasmin","sequence":"first","affiliation":[{"name":"Department of Life Science and Bioinformatics, Assam University, Silchar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4174-1852","authenticated-orcid":false,"given":"Shubhadeep","family":"Roychoudhury","sequence":"additional","affiliation":[{"name":"Department of Life Science and Bioinformatics, Assam University, Silchar, Assam 788011, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallav","family":"Sengupta","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, College of Medicine, Gulf Medical University, Ajman 4184, UAE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abul Barkat Fuzayel","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Silchar Medical College, Silchar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithar","family":"Ranjan Madhu","sequence":"additional","affiliation":[{"name":"Department of Zoology, Acharya Prafulla Chandra College, New Barrackpore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Paul Choudhury","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Silchar Medical College, Silchar, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Kolesarova","sequence":"additional","affiliation":[{"name":"AgroBioTech Research Centre, Slovak University of Agriculture in Nitra, Nitra, Slovak Republic"},{"name":"Institute of Applied Biology, Faculty of Biotechnology and Food Sciences, Slovak University of Agriculture in Nitra, Nitra, Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulagna","family":"Dutta","sequence":"additional","affiliation":[{"name":"Basic Medical Sciences Department, College of Medicine, Ajman University, Ajman, UAE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2765-6176","authenticated-orcid":false,"given":"Israel","family":"Maldonado Rosas","sequence":"additional","affiliation":[{"name":"CITMER Reproductive Medicine, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dey256"},{"key":"e_1_3_4_3_2","doi-asserted-by":"crossref","unstructured":"Teede HJ Misso ML Boyle JA et al. Translation and implementation of the Australian-led PCOS guideline: clinical summary and translation resources from the International Evidence-based Guideline for the Assessment and management of polycystic ovary syndrome. Med J Aust. 2018;209:S3\u2013S8. https:\/\/doi.org\/10.5694\/mja18.00656","DOI":"10.5694\/mja18.00656"},{"key":"e_1_3_4_4_2","unstructured":"World Health Organization.Polycystic ovary syndrome Key facts. WHO https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/polycystic-ovary-syndrome (2023 accessed 8 December 2023)."},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dew218"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmu012"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(15)30642-6"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0628"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0178"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.12.013"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(02)03111-4"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2008.01010.x"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/0167482X.2018.1502265"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-019-0434-8"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.05.003"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_1937_17"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2013.04.004"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1530\/EC-18-0309"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-00078"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.06.035"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/det469"},{"issue":"23","key":"e_1_3_4_22_2","first-page":"25","article-title":"Polycystic ovary syndrome and genetic factors influencing its development: a review article","volume":"6","author":"Piri-Gharaghie T.","year":"2021","unstructured":"Piri-Gharaghie T. Polycystic ovary syndrome and genetic factors influencing its development: a review article. Pers Med J 2021; 6(23): 25\u201329.","journal-title":"Pers Med J"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-2760(98)00021-6"},{"key":"e_1_3_4_24_2","doi-asserted-by":"crossref","unstructured":"Merkin SS Phy JL Sites CK et al. Environmental determinants of polycystic ovary syndrome. Fertil Steril 2016; 106(1): 16. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.05.011","DOI":"10.1016\/j.fertnstert.2016.05.011"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.4274\/jtgga.galenos.2019.2018.0142"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-813209-8.00027-3"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.3390\/life12121974"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1514250"},{"issue":"12","key":"e_1_3_4_30_2","article-title":"Prevalence of polycystic ovarian syndrome in India: a systematic review and meta-analysis","volume":"14","author":"Bharali MD","year":"2022","unstructured":"Bharali MD, Rajendran R, Goswami J, et al. Prevalence of polycystic ovarian syndrome in India: a systematic review and meta-analysis. Cureus 2022; 14(12): e32351.","journal-title":"Cureus"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.4103\/ijph.ijph_15_23"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph15112589"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.4172\/pharmaceutical-sciences.1000269"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064446"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.5455\/njppp.2023.13.10494202314122023"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.4103\/1658-354X.174918"},{"issue":"3","key":"e_1_3_4_37_2","first-page":"227","article-title":"Explaining odds ratios","volume":"19","author":"Szumilas M.","year":"2010","unstructured":"Szumilas M. Explaining odds ratios. J Can Acad Child Adolesc Psychiatry 2010; 19(3): 227.","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"key":"e_1_3_4_38_2","doi-asserted-by":"crossref","unstructured":"von Elm E Altman DG Egger M et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg 2014; 12(12): 1495\u20131499. https:\/\/doi.org\/10.1016\/j.ijsu.2014.07.013","DOI":"10.1016\/j.ijsu.2014.07.013"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.57"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.59.687.17"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1977.tb15179.x"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2013.05.005"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.7241\/ourd.20183.4"},{"key":"e_1_3_4_44_2","unstructured":"Ortho Clinical Diagnostics.VITROS Immunodiagnostic Products: Instructions for Use and Product Specifications. Raritan NJ USA; 2020. Available from: https:\/\/www.orthoclinicaldiagnostics.com\/"},{"key":"e_1_3_4_45_2","unstructured":"World Health Organization. Obesity: preventing and managing the global epidemic: report of a WHO consultation https:\/\/iris.who.int\/handle\/10665\/42330 (2000 accessed 9 December 2023)."},{"key":"e_1_3_4_46_2","unstructured":"Erba Mannheim. EM 200: Fully automated random access clinical chemistry analyzer. A perfect volume for mid volume workload laboratories https:\/\/transasia.co.in\/instrument\/clinical-chemistry\/em-200\/7 (accessed 6 December 2024)."},{"key":"e_1_3_4_47_2","unstructured":"Transasia Bio-Medicals Ltd. 5-Part Fully Automated Hematology Analyzer\u2014Product Brochure. Mumbai: Transasia Bio-Medicals Ltd. https:\/\/adaa.org\/sites\/default\/files\/GAD-7_Anxiety-updated_0.pdf (2024 accessed 11 July 2025)."},{"key":"e_1_3_4_48_2","volume-title":"Guidelines for the management of hypertension","author":"World Health Organization","year":"1999","unstructured":"World Health Organization. Guidelines for the management of hypertension. Fukuoka, Japan: World Health Organization, 1999."},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/occmed\/kqt161"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12784"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.19180"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2013.04.006"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00221"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-024-07607-x"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvae125"},{"issue":"3","key":"e_1_3_4_56_2","first-page":"170","article-title":"Prevalence of polycystic ovary syndrome (PCOS) and its associated symptoms in women in India: a systematic review and meta-analysis","volume":"52","author":"Deswal R","year":"2020","unstructured":"Deswal R, Narwal V, Dang A, et al. Prevalence of polycystic ovary syndrome (PCOS) and its associated symptoms in women in India: a systematic review and meta-analysis. Horm Metab Res 2020; 52(3): 170\u2013176.","journal-title":"Horm Metab Res"},{"issue":"3","key":"e_1_3_4_57_2","first-page":"746","article-title":"Prevalence of polycystic ovarian syndrome among reproductive age group women in South India: a community-based study","volume":"4","author":"Bharathi R","year":"2017","unstructured":"Bharathi R, Swetha S, Kumar J, et al. Prevalence of polycystic ovarian syndrome among reproductive age group women in South India: a community-based study. Int J Community Med Public Health 2017; 4(3): 746\u2013749.","journal-title":"Int J Community Med Public Health"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2350"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmp024"},{"issue":"10","key":"e_1_3_4_60_2","first-page":"2454","article-title":"Prevalence and predictors of PCOS in young women from the Australian Longitudinal Study on Women\u2019s Health","volume":"30","author":"Joham AE","year":"2015","unstructured":"Joham AE, Ranasinha S, Zoungas S, et al. Prevalence and predictors of PCOS in young women from the Australian Longitudinal Study on Women\u2019s Health. Hum Reprod 2015; 30(10): 2454\u20132462.","journal-title":"Hum Reprod"},{"issue":"3","key":"e_1_3_4_61_2","article-title":"Prevalence, diagnosis and management of polycystic ovary syndrome: an Australian perspective","volume":"12","author":"Moran LJ","year":"2023","unstructured":"Moran LJ, Tassone EC, Boyle J, et al. Prevalence, diagnosis and management of polycystic ovary syndrome: an Australian perspective. Endocr Connect 2023; 12(3): e220500.","journal-title":"Endocr Connect"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1989.tb00446.x"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1210\/mend.13.6.0311"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199509283331307"},{"issue":"6","key":"e_1_3_4_65_2","first-page":"2001","article-title":"Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and IGF-I receptor","volume":"83","author":"Nestler JE","year":"1998","unstructured":"Nestler JE, Jakubowicz DJ, de Vargas AF, et al. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and IGF-I receptor. J Clin Endocrinol Metab 1998; 83(6): 2001\u20132005.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-67-3-460"},{"issue":"1","key":"e_1_3_4_67_2","first-page":"147","article-title":"Prevalence of \u201cobesity-associated\u201d functional hyperandrogenism in women with simple obesity","volume":"15","author":"Escobar-Morreale HF","year":"2000","unstructured":"Escobar-Morreale HF, Carretero J, Sancho J, et al. Prevalence of \u201cobesity-associated\u201d functional hyperandrogenism in women with simple obesity. Hum Reprod 2000; 15(1): 147\u2013153.","journal-title":"Hum Reprod"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030727"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2011.08.015"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1080\/14647270701731290"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dms030"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmw025"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007506.pub3"},{"issue":"5","key":"e_1_3_4_74_2","first-page":"942","article-title":"Maternal polycystic ovary syndrome and risk of polycystic ovary syndrome in daughters: a nationwide cohort study","volume":"38","author":"Boldis V","year":"2023","unstructured":"Boldis V, Iversen L, Andersen MS, et al. Maternal polycystic ovary syndrome and risk of polycystic ovary syndrome in daughters: a nationwide cohort study. Hum Reprod 2023; 38(5): 942\u2013949.","journal-title":"Hum Reprod"},{"issue":"2","key":"e_1_3_4_75_2","first-page":"517","article-title":"Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance","volume":"86","author":"Vgontzas AN","year":"2001","unstructured":"Vgontzas AN, Legro RS, Bixler EO, et al. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab 2001; 86(2): 517\u2013520.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2011.10.022"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/13.6.1532"},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2014.04.046"},{"key":"e_1_3_4_79_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1740001"},{"issue":"11","key":"e_1_3_4_80_2","first-page":"1441","article-title":"Diagnostic value of 3D power Doppler sonography in the diagnosis of polycystic ovary syndrome","volume":"28","author":"Panico A","year":"2009","unstructured":"Panico A, Messalli EM, Lupoli GA, et al. Diagnostic value of 3D power Doppler sonography in the diagnosis of polycystic ovary syndrome. J Ultrasound Med 2009; 28(11): 1441\u20131448.","journal-title":"J Ultrasound Med"},{"key":"e_1_3_4_81_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1992.tb02296.x"},{"key":"e_1_3_4_82_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032046"}],"container-title":["Therapeutic Advances in Reproductive Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/26334941251384195","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/26334941251384195","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/26334941251384195","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:11:55Z","timestamp":1777597915000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/26334941251384195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":81,"alternative-id":["10.1177\/26334941251384195"],"URL":"https:\/\/doi.org\/10.1177\/26334941251384195","relation":{},"ISSN":["2633-4941","2633-4941"],"issn-type":[{"value":"2633-4941","type":"print"},{"value":"2633-4941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]},"article-number":"26334941251384195"}}